It is reported that GE Healthcare is considering selling its China business, with a valuation potentially reaching several billion dollars
I'm PortAI, I can summarize articles.
GE Healthcare is considering selling its stake in its business in China, with a valuation potentially reaching several billion dollars. The company is working with advisors to assess the business outlook, and potential transactions are still in the preliminary stages. Due to increased competition from domestic companies, other multinational corporations such as Starbucks and Häagen-Dazs are also considering exiting the Chinese market. GE Healthcare's stock price has fallen 2% this year, and its revenue in the Chinese market is expected to be $2.4 billion in 2024, a decrease of 15% from the previous year
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments